Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-07-30

Clinical Trial Update: Impact of Introducing Basaglar Insulin to the Treatment Regimen of Youth With Diabetes in Pakistan [Phase 4]

View source ↗

Summary

A Phase 4 trial in Pakistan evaluates adding Basaglar insulin (insulin glargine) to the treatment regimen for youth with Type 1 diabetes; the study has complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Basaglar (insulin glargine)

Snippet

Sponsor: Life for a Child Program, Diabetes Australia | Conditions: Type 1 Diabetes | Phase 4 | Status: COMPLETED